InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Jacroux Richard. Director active across 1 company, notably ENDRA Life Sciences Inc.. Cumulatively, 2 reports have been recorded. History available since 21 January 2026. The latest transaction was filed on 2 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations